The FINANCIAL — Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Milestone strengthens the company’s leadership in advanced IOL innovation FINEVISION HP, with millions of implantations worldwide, will now be available to U.S. patients Proprietary design features ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...
The Clareon PanOptix Pro Trifocal IOL is a type of multifocal IOL used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL) has surpassed more than one million ...
The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...
Please provide your email address to receive an email when new articles are posted on . Trifocal IOLs may be an option for patients with less-than-perfect eyes, but selection should be made case by ...
LEINFELDEN-ECHTERDINGEN, GERMANY, August 27, 2025 /EINPresswire.com/ -- In the field of ophthalmology, particularly with premium intraocular lenses (IOLs), patient ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...
“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...